Is Semaglutide legal in Netherlands?

Semaglutide is among the peptides readers most often ask about in Netherlands. This page focuses on the regulatory reality there, not on how to obtain or use it, because that is where reliable, localized information is hardest to find.

In Netherlands, Semaglutide is an authorised, prescription-only medicine, regulated by CBG-MEB (Medicines Evaluation Board) / IGJ (Health and Youth Care Inspectorate). It holds an EU-wide marketing authorisation granted through the European Medicines Agency (EMA), sold as Ozempic and Rybelsus for type-2 diabetes and Wegovy for weight management, valid across the EU and EEA.

Semaglutide is supplied through pharmacies on prescription. Importing prescription medicines outside regulated channels is restricted, and customs may detain shipments. Holding Semaglutide on a valid prescription is lawful in Netherlands; obtaining or holding it without a prescription is not.

Selling or supplying Semaglutide without the required authorisation is an offence in Netherlands. CBG-MEB (Medicines Evaluation Board) / IGJ (Health and Youth Care Inspectorate) sets out the applicable sanctions; we do not reproduce specific figures here because they change. Confirm the current penalties with the regulator. This page reflects our reading of the position as of the last-verified date; regulations change, so confirm with CBG-MEB (Medicines Evaluation Board) / IGJ (Health and Youth Care Inspectorate) before making any decision.